I have spent a majority of my 20 year nursing career working as a clinical research nurse. I have had the honor of working with top researchers in the field of chronic kidney disease and solid organ transplantation including: Joel Copper, M.D., Daniel Brennan, M.D., J.R. Thistlethwaite, M.D, and Sandra Cupples, Ph.D., R.N. I have been educated in all aspects of conducting clinical research, the Code of Federal Regulations governing research in the United States, and the key concepts and principles related to Good Clinical Practice (GCP), and have been involved in the successful implementation of over 40 industry sponsored and/or investigator initiated clinical trials.
As the recipient of the 2013 Edith Anderson Education Leadership Award from The Honor Society of Nursing: Sigma Theta Tau International (STTI) and the 2013 & 2015 International Transplant Nurses Society (ITNS) Research Grant Awards, I have a proven track record of success in grant writing and obtaining competitive research awards. Since 2012, with the help of these funding agencies, I have successfully recruited and managed a multidisciplinary team of nurses, physicians, and outreach coordinators and overseen the completion of two cross-sectional studies and a prospective clinical trial cumulatively involving over 600 subjects. I have also begun to develop my reputation as a leader in nursing locally as evidenced by my election and service as the co-chair of the University of Chicago Evidence-based Practice and Research Council from 2013-2016, and internationally as evidenced by my recent election to the board of the ITNS as Director at Large.
- 1997 President’s Service Excellence Award, Barnes-Jewish Hospital, St. Louis, MO
- 2005 Certified Clinical Research Coordinator, Association of Clinical Research Professionals
- 2011 Induction, The Honors Society of Nursing, Sigma Theta Tau International
- 2011 Dean’s scholarship, Oregon Health and Science University School of Nursing
- 2015 Semifinalist, Uchicago App Challenge, University of Chicago
- 2016 Service Excellence Award: University of Chicago Nursing EBP and Research Council
- 2016-present International Transplant Nurses Society Board of Directors: Director at Large
Lockwood, M.B., Saunders, M. , McGivern, C., Nass, R., Becker, Y.T., Josephson, M.A., Chon, W.J., and Lee, C.S. (2017). Patient-reported Barriers to the Pre-kidney Transplant Evaluation in an At-risk Population in the United States. Progress in Transplantation, In Press.
Lockwood, M.B., Bidwell, J., Werner, D., & Lee, C.S. (2016). Non-biological barriers to referral and the pre-kidney transplant evaluation among African Americans in the United States: A systematic review. Nephrology Nursing Journal, 43(3), 225-238.
Lockwood, M., Saunders, M., Josephson, M, Becker, Y., & Lee, C. (2015). Determinants of frequent Internet use in an urban kidney transplant population in the United States: Characterizing the digital divide. Progress in Transplantation, 25(1), 1-9.
Lockwood, M.B., Saunders, M. Lee, C.S., Becker, Y.T., Josephson, M.A., and Chon, W.J., (2013). Renal Transplantation and the Digital Divide: Does Information and Communication Technology Represent a Barrier or a Bridge to Transplantation for African Americans? Progress in Transplantation, 23(4), 302-9. DOI: 10.7182/pit20113869.
Khoury JA, Storch GA, Bohl DL, Schuessler RM, Torrence SM, Lockwood MB, Gaudreault-Keener M, Koch MJ, Miller BW, Hardinger KL, Schnitzler MA, Brennan DC: Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. American Journal of Transplantation, 2006; 6: 1-10.
Hardinger KL, Bohl D, Schnitzler MA, Lockwood MB, Storch GA, Brennan DC: A randomized, pharmacoeconomics trial of tacrolimus versus cyclosporine in combination with Thymoglobulin in renal transplant recipients. Transplantation, 2005; 80: 41-46.
Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood MB, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant, 5:582-594, 2005.
Brennan DC, Hardinger KL, Bohl DL, Lockwood MB, Torrence Louis, MO, J Am Soc Nephrol 15, Abstract SA-FC009 pp 23A, 2004.S, Schuessler R, Gaudreault M, Roby T, Koch MJ, Miller BW, Schnitzler MA, Storch GA: Preemptive vs prophylactic valganciclovir for CMV in renal transplantation: Early results from a randomized, prospective trial. American Society of Nephrology 2004, St.
My research program has four main components: 1) advancing symptom science through the identification of symptom clusters in patients with chronic kidney disease, 2) Exploring the effects of the gut microbiome on symptoms and adverse outcomes in pre-and post-kidney transplant recipients, 3) Continuing work understanding the nuances of information and communication technology use among patients with chronic illness, and 4) Reducing existing health disparities/inequities by developing of innovative strategies leveraging other areas of my research program.
My next step is to expand the vision and scope of my research program to include reduction of the symptom burden experienced by those suffering with CKD to improve daily functioning and HRQoL. First, I will conduct a rigorous assessment of the patient’s symptom experience using the prospective data from nearly 4000 patients from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Chronic Renal Insufficiency cohort (CRIC) study. We will use novel statistical methods to characterize how symptoms cluster and change over the course of the disease process. In addition, I will begin work exploring how the gut microbiome, which comprises 99% of the genetic material in our bodies, contributes to a patient’s symptom experience in a prospective study of patients with end stage renal disease who progress to kidney transplantation. This work will be done in conjunction with Dr. David Perkins and colleagues at the Finn-Perkins (microbiome) Laboratory at UIC. By the end of my career I hope that patients with CKD can experience a symptom, check their structure and composition of their microbiome on their hand held device, and receive recommendations on what pre/probiotics they should consume, through diet or supplementation, to relieve the symptoms.